speb/financial-data huggingface dataset:
Financial ratios for GPRK — quarterly report dated 2025-06-30
Total revenue: 29683.751957655175
Gross profit: 14422.71474733858
Operating income: 9446.55353567393
Net income: -2561.0590171084195
Capital expenditures: 0
Net tangible assets: 50409.12515116072
Owner earnings: -2561.0590171084195
Return on net tangible assets (%): -5.080546447550178
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.48
P/E ratio: 455259.358333642
Shares outstanding: 64895753
Book value: 50409.125151160755
P/B ratio: 8342.22927255695
Market cap (USD): 420524479.44000006
Debt to equity: 3.204052639082107
Current ratio: 2.4730596344021576
Quick ratio: 2.419898112076716
Interest coverage ratio: 2.517400779237932
COGS to revenue (%): 51.412089792715406
SG&A to revenue (%): 8.65703290006428
Buyback yield (%): 0
Retained earnings: 27622.76232579347
Inventory turnover: 7.714518351496931
Receivables turnover: 1.8507354304431123
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.147008238318351
Rule of 40 score: 0
Financial ratios for GPRK — quarterly report dated 2025-09-30
Total revenue: 31517.478948711407
Gross profit: 14526.92013268691
Operating income: 8594.02908905333
Net income: 4048.4817555498853
Capital expenditures: 4471.548864506251
Operating cash flow: 11635.621331972441
Depreciation & amortization: 7312.579739729523
Net tangible assets: 53227.86425108446
Owner earnings: 6889.512630773156
Return on net tangible assets (%): 12.943432406519657
Capex to operating income (%): 52.030878859857474
Buffett classification: The Good
Stock price: 6.33
P/E ratio: 82617.6275890889
Shares outstanding: 64895753
Book value: 53227.86425108448
P/B ratio: 7717.576541343765
Market cap (USD): 410790116.49
Debt to equity: 2.734419942473633
Current ratio: 2.6305220883534135
Quick ratio: 2.571887550200803
Effective tax rate (%): 19.97780803954204
Interest coverage ratio: 2.3817268934304505
COGS to revenue (%): 50.141276099646205
SG&A to revenue (%): 16.028562869888354
Free cash flow (dilution-adjusted): 11438.37713702475
Buyback yield (%): 0
Inventory turnover: 8.483972602739726
Receivables turnover: 2.794502262443439
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8159981871742583
FCF margin (%): 36.29217030854052
Revenue growth (%): 6.177544515504988
Rule of 40 score: 42.46971482404551
Financial ratios for GPRK — annual report dated 2025-12-31
Total revenue: 131673.1097244724
Gross profit: 62631.06676718906
Operating income: 41426.45556963582
Net income: 13278.313362527604
Capital expenditures: 26295.696251263213
Operating cash flow: 3931.334648679574
Depreciation & amortization: 31330.37113082348
Net tangible assets: 65713.04064206006
Owner earnings: 18312.988242087875
Return on net tangible assets (%): 27.868118813492444
Capex to operating income (%): 63.47561211714444
Buffett classification: The Good
Stock price: 7.37
P/E ratio: 36019.76294366925
Shares outstanding: 64895753
Book value: 65713.04064206008
P/B ratio: 7278.337677527473
Market cap (USD): 478281699.61
Debt to equity: 2.35780745900072
Current ratio: 1.6008452962180282
Quick ratio: 1.5106390730889747
Effective tax rate (%): -2.0883435078415657
Interest coverage ratio: 2.8653796368208884
COGS to revenue (%): 52.43442879245022
SG&A to revenue (%): 11.240401366041445
Free cash flow (dilution-adjusted): -23558.59974441646
Buyback yield (%): 0
Retained earnings: 40099.613416531654
Inventory turnover: 20.86186283221585
Receivables turnover: 6.0439813962620725
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.15578869751123
FCF margin (%): -17.89173187578931
Revenue growth (%): -12.277362635964389
Rule of 40 score: -30.1690945117537
Financial ratios for GPRK — quarterly report dated 2025-12-31
Total revenue: 31150.714083294566
Gross profit: 13171.90933735423
Operating income: 7179.330884436674
Net income: 8305.662939852318
Capital expenditures: 0
Operating cash flow: 14680.54731236265
Net tangible assets: 65713.04064206006
Owner earnings: 8305.662939852318
Return on net tangible assets (%): 12.639291773292596
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.37
P/E ratio: 48838.712875769445
Shares outstanding: 64895753
Book value: 65713.04064206008
P/B ratio: 7278.337677527473
Market cap (USD): 478281699.61
Debt to equity: 2.35780745900072
Current ratio: 1.6008452962180282
Quick ratio: 1.5106390730889747
Effective tax rate (%): -413.41926954222447
Interest coverage ratio: 2.3193988599067197
COGS to revenue (%): 57.71554609588219
SG&A to revenue (%): 12.840076211400813
Free cash flow (dilution-adjusted): 830.1118044304711
Buyback yield (%): 0
Retained earnings: 40099.613416531654
Inventory turnover: 5.432506664512481
Receivables turnover: 1.4298616991250352
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.973150416787992
FCF margin (%): 2.664824318989341
Revenue growth (%): -1.1636871908875688
Rule of 40 score: 1.5011371281017722
Financial ratios for HGBL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.87
Shares outstanding: 34734754
Market cap (USD): 64953989.980000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HGBL — annual report dated 2022-12-31
Total revenue: 46914000
Gross profit: 10392000
Operating income: 4142000
Net income: 15493000
Capital expenditures: 215000
Operating cash flow: 6483000
Depreciation & amortization: 536000
Net tangible assets: 36709000
Owner earnings: 15814000
Return on net tangible assets (%): 43.07935383693372
Capex to operating income (%): 5.190729116368904
Buffett classification: The Great
Stock price: 2.35
P/E ratio: 5.268616271864714
Shares outstanding: 34734754
Book value: 48299000
P/B ratio: 1.6900281972711653
Market cap (USD): 81626671.9
Debt to equity: 0.14801548686308205
Current ratio: 1.4724516208554173
Quick ratio: 1.1877850363613953
Effective tax rate (%): -40.755882620150814
Interest coverage ratio: 36.65486725663717
COGS to revenue (%): 77.84882977362834
SG&A to revenue (%): 12.179733128703585
Free cash flow (dilution-adjusted): 5728000
Buyback yield (%): 0.4839104557440617
Retained earnings: -245270000
Inventory turnover: 7.9069062567655335
Receivables turnover: 8.540688148552704
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.068726380176882
FCF margin (%): 12.209574966960822
Rule of 40 score: 12.209574966960822
Financial ratios for HGBL — annual report dated 2023-12-31
Total revenue: 60545000
Gross profit: 21394000
Operating income: 13260000
Net income: 12475000
Capital expenditures: 257000
Operating cash flow: 13021000
Depreciation & amortization: 1156000
Net tangible assets: 49881000
Owner earnings: 13374000
Return on net tangible assets (%): 26.81181211282853
Capex to operating income (%): 1.93815987933635
Buffett classification: The Great
Stock price: 2.78
P/E ratio: 7.740490270140279
Shares outstanding: 34734754
Book value: 61080000
P/B ratio: 1.580920368696791
Market cap (USD): 96562616.11999999
Debt to equity: 0.16168958742632614
Current ratio: 1.7844441427989683
Quick ratio: 1.4400705850414008
Effective tax rate (%): 10.861021793497677
Interest coverage ratio: 40.925925925925924
COGS to revenue (%): 64.66429928152614
SG&A to revenue (%): 11.710298125361302
Free cash flow (dilution-adjusted): 11988000
Buyback yield (%): 0.4142389840628523
Retained earnings: -233026000
Inventory turnover: 7.716003153330705
Receivables turnover: 7.1304911082322455
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.376333401525557
FCF margin (%): 19.800148649764637
Revenue growth (%): 29.055292663170906
Rule of 40 score: 48.85544131293554
Financial ratios for HGBL — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 311000
Buffett classification: The Gruesome
Stock price: 1.7
Shares outstanding: 34734754
Market cap (USD): 59049081.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HGBL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.85
Shares outstanding: 34734754
Market cap (USD): 64259294.900000006
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HGBL — annual report dated 2024-12-31
Total revenue: 45361000
Gross profit: 14212000
Operating income: 6378000
Net income: 5182000
Capital expenditures: 137000
Operating cash flow: 7745000
Depreciation & amortization: 1248000
Net tangible assets: 54393000
Owner earnings: 6293000
Return on net tangible assets (%): 11.569503428750023
Capex to operating income (%): 2.148008780181875
Buffett classification: The Great
Stock price: 1.85
P/E ratio: 12.400481455036665
Shares outstanding: 34734754
Book value: 65201000
P/B ratio: 0.9855568917654638
Market cap (USD): 64259294.900000006
Debt to equity: 0.0415944540727903
Current ratio: 2.269351966022743
Quick ratio: 1.9030004110152077
Effective tax rate (%): 42.248969129611055
Interest coverage ratio: 68.58064516129032
COGS to revenue (%): 68.66912105112321
SG&A to revenue (%): 16.556072396993013
Free cash flow (dilution-adjusted): 6355000
Buyback yield (%): 3.420516834833803
Retained earnings: -227844000
Inventory turnover: 5.824420344053852
Receivables turnover: 9.117788944723618
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.560642172954985
FCF margin (%): 14.009832234739092
Revenue growth (%): -25.07886695846065
Rule of 40 score: -11.06903472372156
Financial ratios for HGBL — quarterly report dated 2025-03-31
Total revenue: 13459000
Gross profit: 3380000
Operating income: 1359000
Net income: 1064000
Capital expenditures: 7408000
Operating cash flow: 2617000
Depreciation & amortization: 118000
Net tangible assets: 54684000
Owner earnings: -6226000
Return on net tangible assets (%): -11.385414380806086
Capex to operating income (%): 545.1066961000736
Buffett classification: The Gruesome
Stock price: 2.18
P/E ratio: 17.791767791353386
Shares outstanding: 34734754
Book value: 65426000
P/B ratio: 1.1573650187998656
Market cap (USD): 75721763.72
Debt to equity: 0.09957814935958181
Current ratio: 1.996817874069059
Quick ratio: 1.652809749492214
Effective tax rate (%): 27.07333790267306
COGS to revenue (%): 74.8866929192362
SG&A to revenue (%): 14.168957574856972
Free cash flow (dilution-adjusted): -5071000
Buyback yield (%): 1.3760905039838394
Retained earnings: -226780000
Inventory turnover: 1.9836646329462704
Receivables turnover: 2.6483667847304213
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8897834883817948
FCF margin (%): -37.677390593654806
Rule of 40 score: -37.677390593654806
Financial ratios for HGBL — quarterly report dated 2025-06-30
Total revenue: 14304000
Gross profit: 4069000
Operating income: 2153000
Net income: 1637000
Capital expenditures: 159000
Operating cash flow: 1879000
Depreciation & amortization: 458000
Net tangible assets: 55029000
Owner earnings: 1936000
Return on net tangible assets (%): 3.5181449781024554
Capex to operating income (%): 7.385044124477473
Buffett classification: The Great
Stock price: 2.22
P/E ratio: 28.549112876712332
Shares outstanding: 34734754
Book value: 65706000
P/B ratio: 1.1735785754725598
Market cap (USD): 77111153.88000001
Debt to equity: 0.0944966974096734
Current ratio: 2.0488769780500253
Quick ratio: 1.6898928024502298
Effective tax rate (%): 27.244444444444444
COGS to revenue (%): 71.55341163310962
SG&A to revenue (%): 12.576901565995527
Free cash flow (dilution-adjusted): 1491000
Buyback yield (%): 2.055474364274939
Retained earnings: -225143000
Inventory turnover: 1.8192321365090651
Receivables turnover: 2.4674831809556665
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.989696447912906
FCF margin (%): 10.423657718120806
Revenue growth (%): 6.278326770190951
Rule of 40 score: 16.70198448831176
Financial ratios for HGBL — quarterly report dated 2025-09-30
Total revenue: 11360000
Gross profit: 4425000
Operating income: 1212000
Net income: 585000
Capital expenditures: 294000
Operating cash flow: 61000
Depreciation & amortization: 294000
Net tangible assets: 55885000
Owner earnings: 585000
Return on net tangible assets (%): 1.046792520354299
Capex to operating income (%): 24.257425742574256
Buffett classification: The Great
Stock price: 1.66
P/E ratio: 17.547075970785148
Shares outstanding: 34734754
Book value: 66495000
P/B ratio: 0.8671282297917137
Market cap (USD): 57659691.64
Debt to equity: 0.08871343710053388
Current ratio: 2.2900345622119818
Quick ratio: 1.8860167050691243
Effective tax rate (%): 56.17977528089888
COGS to revenue (%): 61.0475352112676
SG&A to revenue (%): 27.508802816901408
Free cash flow (dilution-adjusted): -437000
Buyback yield (%): 0
Retained earnings: -224558000
Inventory turnover: 1.2359650686152202
Receivables turnover: 1.8942804735701184
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6689387367290451
FCF margin (%): -3.8468309859154926
Revenue growth (%): -20.581655480984338
Rule of 40 score: -24.42848646689983
Financial ratios for HGBL — quarterly report dated 2025-12-31
Total revenue: 11855000
Gross profit: -806000
Operating income: 864000
Net income: 301000
Capital expenditures: 609000
Operating cash flow: 1580000
Depreciation & amortization: 293000
Net tangible assets: 56437000
Owner earnings: -15000
Return on net tangible assets (%): -0.026578308556443466
Capex to operating income (%): 70.48611111111111
Buffett classification: The Good
Stock price: 1.24
P/E ratio: 12.00755365486479
Shares outstanding: 34734754
Book value: 66983000
P/B ratio: 0.6430153167221534
Market cap (USD): 43071094.96
Debt to equity: 0.08537987250496394
Current ratio: 2.1621934736435606
Quick ratio: 1.7804595481753234
Effective tax rate (%): 62.421972534332085
COGS to revenue (%): 106.7988190636862
SG&A to revenue (%): -15.20033741037537
Free cash flow (dilution-adjusted): 784000
Buyback yield (%): 0
Retained earnings: -224257000
Inventory turnover: 2.134715899511044
Receivables turnover: 1.8566953797963979
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1851526707086226
FCF margin (%): 6.613243357233236
Revenue growth (%): 4.357394366197183
Rule of 40 score: 10.970637723430418
Financial ratios for HGBL — annual report dated 2025-12-31
Total revenue: 50978000
Gross profit: 13804000
Operating income: 5588000
Net income: 3587000
Capital expenditures: 8470000
Operating cash flow: 6137000
Depreciation & amortization: 1163000
Net tangible assets: 56437000
Owner earnings: -3720000
Return on net tangible assets (%): -6.59142052199798
Capex to operating income (%): 151.57480314960628
Buffett classification: The Gruesome
Stock price: 1.24
P/E ratio: 12.00755365486479
Shares outstanding: 34734754
Book value: 66983000
P/B ratio: 0.6430153167221534
Market cap (USD): 43071094.96
Debt to equity: 0.08537987250496394
Current ratio: 2.1621934736435606
Quick ratio: 1.7804595481753234
Effective tax rate (%): 38.63130881094953
COGS to revenue (%): 72.92165247753934
SG&A to revenue (%): 15.230099258503667
Free cash flow (dilution-adjusted): -3233000
Buyback yield (%): 6.099218054334786
Retained earnings: -224257000
Inventory turnover: 6.267745742707806
Receivables turnover: 7.984025058731402
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.665084634166415
FCF margin (%): -6.34195143002864
Revenue growth (%): 12.382883975221006
Rule of 40 score: 6.040932545192366
Financial ratios for HNRG — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.46
Shares outstanding: 47130392
Market cap (USD): 115940764.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HNRG — annual report dated 2022-12-31
Total revenue: 361991000
Gross profit: 95383000
Operating income: 30430000
Net income: 18105000
Capital expenditures: 655000
Operating cash flow: 54169000
Depreciation & amortization: 46875000
Net tangible assets: 215024000
Owner earnings: 64325000
Return on net tangible assets (%): 29.915265272713743
Capex to operating income (%): 2.1524811041735132
Buffett classification: The Great
Stock price: 9.99
P/E ratio: 26.005667830985917
Shares outstanding: 47130392
Book value: 215024000
P/B ratio: 2.1896747157526604
Market cap (USD): 470832616.08
Debt to equity: 0.4731750874321006
Current ratio: 0.5781212176859959
Quick ratio: 0.25220156759960266
Effective tax rate (%): 8.841448064045114
Interest coverage ratio: 3.6760086977530806
COGS to revenue (%): 73.65044987306314
SG&A to revenue (%): 4.5351956264106015
Free cash flow (dilution-adjusted): -1120000
Buyback yield (%): 0
Retained earnings: 95906000
Inventory turnover: 3.41406820248172
Receivables turnover: 7.319455677774183
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.783564222717879
FCF margin (%): -0.30939995745750587
Rule of 40 score: -0.30939995745750587
Financial ratios for HNRG — annual report dated 2023-12-31
Total revenue: 634878000
Gross profit: 331635000
Operating income: 65410000
Net income: 44793000
Capital expenditures: 62000
Operating cash flow: 59414000
Depreciation & amortization: 67211000
Net tangible assets: 268588000
Owner earnings: 111942000
Return on net tangible assets (%): 41.67796029606684
Capex to operating income (%): 0.09478672985781991
Buffett classification: The Great
Stock price: 8.84
P/E ratio: 9.30128960507222
Shares outstanding: 47130392
Book value: 268588000
P/B ratio: 1.5511961267070755
Market cap (USD): 416632665.28
Debt to equity: 0.4429870284599461
Current ratio: 0.5889400044417653
Quick ratio: 0.19583108601161203
Effective tax rate (%): 9.064517438791668
Interest coverage ratio: 6.242603550295858
COGS to revenue (%): 47.763979851247015
SG&A to revenue (%): 28.127608768928837
Free cash flow (dilution-adjusted): -19492000
Buyback yield (%): 0
Retained earnings: 140699000
Inventory turnover: 4.8948056559917354
Receivables turnover: 31.844209259166373
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.134722398972661
FCF margin (%): -3.0701961636723905
Revenue growth (%): 75.38502338455928
Rule of 40 score: 72.31482722088688
Financial ratios for HNRG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.43
Shares outstanding: 47130392
Market cap (USD): 444439596.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HNRG — annual report dated 2024-12-31
Total revenue: 404159000
Gross profit: 225564000
Operating income: -555000
Net income: -226138000
Capital expenditures: 4239000
Operating cash flow: 65934000
Depreciation & amortization: 65626000
Net tangible assets: 104285000
Owner earnings: -164751000
Return on net tangible assets (%): -157.98149302392483
Buffett classification: The Gruesome
Stock price: 11.45
Shares outstanding: 47130392
Book value: 104285000
P/B ratio: 5.174694235987917
Market cap (USD): 539642988.4
Debt to equity: 0.54801745217433
Current ratio: 0.6857811815333904
Quick ratio: 0.19011399383923142
Interest coverage ratio: -0.04585639923985789
COGS to revenue (%): 44.18929183811322
SG&A to revenue (%): 35.30565940632276
Free cash flow (dilution-adjusted): 8113000
Buyback yield (%): 0
Retained earnings: -85439000
Inventory turnover: 2.35647653353389
Receivables turnover: 26.179492162197175
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.25668656951118557
FCF margin (%): 2.007378284289104
Revenue growth (%): -36.34068277684847
Rule of 40 score: -34.333304492559364
Financial ratios for HNRG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.45
Shares outstanding: 47130392
Market cap (USD): 539642988.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HNRG — quarterly report dated 2025-03-31
Total revenue: 117724000
Gross profit: 67285000
Operating income: 13854000
Net income: 9979000
Capital expenditures: 21000
Operating cash flow: 38419000
Depreciation & amortization: 14977000
Net tangible assets: 115348000
Owner earnings: 24935000
Return on net tangible assets (%): 21.617193189305407
Capex to operating income (%): 0.151580770896492
Buffett classification: The Great
Stock price: 12.28
P/E ratio: 14.499479250425894
Shares outstanding: 47130392
Book value: 115348000
P/B ratio: 5.017522746471546
Market cap (USD): 578761213.76
Debt to equity: 0.3030221590317994
Current ratio: 0.6046359261685832
Quick ratio: 0.17281363667171226
Effective tax rate (%): 0
Interest coverage ratio: 4.294482331060136
COGS to revenue (%): 42.84512928544732
SG&A to revenue (%): 28.75709286126873
Free cash flow (dilution-adjusted): 25642000
Buyback yield (%): 0
Retained earnings: -75460000
Inventory turnover: 0.6597214047478909
Receivables turnover: 9.35654109044667
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.32841386971356
FCF margin (%): 21.781454928476776
Rule of 40 score: 21.781454928476776
Financial ratios for HNRG — quarterly report dated 2025-06-30
Total revenue: 102889000
Gross profit: 56699000
Operating income: 11815000
Net income: 8248000
Capital expenditures: 141000
Operating cash flow: 11364000
Depreciation & amortization: 5542000
Net tangible assets: 122153000
Owner earnings: 13649000
Return on net tangible assets (%): 11.173692009201574
Capex to operating income (%): 1.193398222598392
Buffett classification: The Great
Stock price: 15.83
P/E ratio: 40.932358882975805
Shares outstanding: 47130392
Book value: 122153000
P/B ratio: 6.107701860453694
Market cap (USD): 746074105.36
Debt to equity: 0.4536933190343258
Current ratio: 0.668438030154596
Quick ratio: 0.2559030847530525
Effective tax rate (%): 0
Interest coverage ratio: 3.5857359635811834
COGS to revenue (%): 44.89304007231094
SG&A to revenue (%): 33.33689704438764
Free cash flow (dilution-adjusted): -2155000
Buyback yield (%): 0
Retained earnings: -67212000
Inventory turnover: 0.5350709527946713
Receivables turnover: 5.489755629068402
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.899889143005523
FCF margin (%): -2.094490178736308
Revenue growth (%): -12.601508613366857
Rule of 40 score: -14.695998792103165
Financial ratios for HNRG — quarterly report dated 2025-09-30
Total revenue: 146846000
Gross profit: 73238000
Operating income: 26725000
Net income: 23884000
Capital expenditures: 2729000
Operating cash flow: 23195000
Depreciation & amortization: 9142000
Net tangible assets: 146188000
Owner earnings: 30297000
Return on net tangible assets (%): 20.72468328453772
Capex to operating income (%): 10.211412535079512
Buffett classification: The Great
Stock price: 19.57
P/E ratio: 21.902632837975826
Shares outstanding: 47130392
Book value: 146188000
P/B ratio: 6.309285108490437
Market cap (USD): 922341771.44
Debt to equity: 0.3641406955427258
Current ratio: 0.6585385850771894
Quick ratio: 0.3112560104559024
Effective tax rate (%): 0
Interest coverage ratio: 6.1465041398344065
COGS to revenue (%): 50.12598232161585
SG&A to revenue (%): 22.025795731582747
Free cash flow (dilution-adjusted): 3070000
Buyback yield (%): 0
Retained earnings: -43328000
Inventory turnover: 1.0222197533607378
Receivables turnover: 5.930056939789202
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.222735683822002
FCF margin (%): 2.090625553300737
Revenue growth (%): 42.72274004023754
Rule of 40 score: 44.81336559353828
Financial ratios for HNRG — annual report dated 2025-12-31
Total revenue: 469466000
Gross profit: 255474000
Operating income: 58567000
Net income: 41871000
Capital expenditures: 3158000
Operating cash flow: 81134000
Depreciation & amortization: 41222000
Net tangible assets: 159833000
Owner earnings: 79935000
Return on net tangible assets (%): 50.01157458096889
Capex to operating income (%): 5.392115013574196
Buffett classification: The Great
Stock price: 19.04
P/E ratio: 21.4316033455136
Shares outstanding: 47130392
Book value: 159833000
P/B ratio: 5.614376653632228
Market cap (USD): 897362663.68
Debt to equity: 0.24041968804940156
Current ratio: 0.8085542784498237
Quick ratio: 0.22934823921049527
Effective tax rate (%): 4.194124107633169
Interest coverage ratio: 3.9298798899550427
COGS to revenue (%): 45.582001678502806
SG&A to revenue (%): 29.161643228689616
Free cash flow (dilution-adjusted): 8390000
Buyback yield (%): 0
Retained earnings: -43568000
Inventory turnover: 2.4210526315789473
Receivables turnover: 33.55965401386804
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.926901832445363
FCF margin (%): 1.78713687466185
Revenue growth (%): 16.158739505986507
Rule of 40 score: 17.945876380648357
Financial ratios for HNRG — quarterly report dated 2025-12-31
Total revenue: 101944000
Gross profit: 58189000
Operating income: 6110000
Net income: -240000
Capital expenditures: 267000
Operating cash flow: 8156000
Depreciation & amortization: 11561000
Net tangible assets: 159833000
Owner earnings: 11054000
Capex to operating income (%): 4.369885433715221
Buffett classification: The Great
Stock price: 19.04
P/E ratio: 21.4316033455136
Shares outstanding: 47130392
Book value: 159833000
P/B ratio: 5.614376653632228
Market cap (USD): 897362663.68
Debt to equity: 0.24041968804940156
Current ratio: 0.8085542784498237
Quick ratio: 0.22934823921049527
Effective tax rate (%): 115.06591337099812
Interest coverage ratio: 1.5146256817055033
COGS to revenue (%): 42.92062308718512
SG&A to revenue (%): 35.711763321039
Free cash flow (dilution-adjusted): -18167000
Buyback yield (%): 0
Retained earnings: -43568000
Inventory turnover: 0.49503326243381457
Receivables turnover: 7.287440131531918
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3918481430881067
FCF margin (%): -17.820568155065526
Revenue growth (%): -30.577611919970582
Rule of 40 score: -48.39818007503611
Financial ratios for INVE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.14
Shares outstanding: 24006212
Market cap (USD): 675534805.6800001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INVE — annual report dated 2022-12-31
Total revenue: 112915000
Gross profit: 40944000
Operating income: -131000
Net income: -392000
Capital expenditures: 3902000
Operating cash flow: -7807000
Depreciation & amortization: 2272000
Net tangible assets: 59939000
Owner earnings: -2022000
Return on net tangible assets (%): -3.373429653481039
Buffett classification: The Gruesome
Stock price: 7.24
Shares outstanding: 24006212
Book value: 75394000
P/B ratio: 2.30528921240417
Market cap (USD): 173804974.88
Debt to equity: 0.0604292118736239
Current ratio: 3.210276578463643
Quick ratio: 1.9723849014662507
Interest coverage ratio: -0.916083916083916
COGS to revenue (%): 63.73909578001151
R&D to revenue (%): 8.781827038037463
SG&A to revenue (%): 27.595093654518887
Free cash flow (dilution-adjusted): -14870000
Buyback yield (%): 0
Retained earnings: -409381000
Inventory turnover: 2.4853581048414948
Receivables turnover: 4.548255860791106
Capitalized R&D asset: 9916000
ROCI (R&D-adjusted, %): 7.257040886419974
FCF margin (%): -13.169198069344196
Rule of 40 score: -13.169198069344196
Financial ratios for INVE — annual report dated 2023-12-31
Total revenue: 43445000
Gross profit: 6010000
Operating income: -13348000
Net income: -5489000
Capital expenditures: 4284000
Operating cash flow: 1157000
Depreciation & amortization: 2732000
Net tangible assets: 74272000
Owner earnings: -7041000
Return on net tangible assets (%): -9.480019388194744
Buffett classification: The Gruesome
Stock price: 8.24
Shares outstanding: 24006212
Book value: 74272000
P/B ratio: 2.6633345928479106
Market cap (USD): 197811186.88
Debt to equity: 0.16477272727272727
Current ratio: 2.5822233772984213
Quick ratio: 2.1713014099148853
Interest coverage ratio: -31.259953161592506
COGS to revenue (%): 86.16641730924157
R&D to revenue (%): 10.125445966164115
SG&A to revenue (%): 34.43204051099091
Free cash flow (dilution-adjusted): -7098000
Buyback yield (%): 0
Retained earnings: -414870000
Inventory turnover: 2.9595224918965926
Receivables turnover: 6.055896292166156
Capitalized R&D asset: 11042720
ROCI (R&D-adjusted, %): -15.247943368718994
Rosenberg metric: -3.5229931423961274
FCF margin (%): -16.337898492346646
Revenue growth (%): -61.524155338086175
Rule of 40 score: -77.86205383043281
Financial ratios for INVE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.53
Shares outstanding: 24006212
Market cap (USD): 84741928.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INVE — annual report dated 2024-12-31
Total revenue: 26628000
Gross profit: 340000
Operating income: -27421000
Net income: 74820000
Capital expenditures: 1493000
Operating cash flow: -15433000
Depreciation & amortization: 4343000
Net tangible assets: 154069000
Owner earnings: 77670000
Return on net tangible assets (%): 50.41247752630314
Buffett classification: The Gruesome
Stock price: 3.66
P/E ratio: 1.1743215172413792
Shares outstanding: 24006212
Book value: 154069000
P/B ratio: 0.570281730393525
Market cap (USD): 87862735.92
Debt to equity: 0.013104518105524147
Current ratio: 19.201633165829147
Quick ratio: 18.262562814070353
COGS to revenue (%): 98.72314856541986
R&D to revenue (%): 14.597416253567674
SG&A to revenue (%): 89.65750337990086
Free cash flow (dilution-adjusted): -25656000
Buyback yield (%): 2.1385630441907137
Retained earnings: -340050000
Inventory turnover: 3.516789297658863
Receivables turnover: 6.318936877076412
Capitalized R&D asset: 10106610
ROCI (R&D-adjusted, %): -17.899888217411277
Rosenberg metric: -1.2889293021141168
FCF margin (%): -96.34970707525913
Revenue growth (%): -38.70871216480607
Rule of 40 score: -135.0584192400652
Financial ratios for INVE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.66
Shares outstanding: 24006212
Market cap (USD): 87862735.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INVE — quarterly report dated 2025-03-31
Total revenue: 5269000
Gross profit: 132000
Operating income: -5208000
Net income: -4789000
Capital expenditures: 301000
Operating cash flow: -3280000
Depreciation & amortization: 653000
Net tangible assets: 150499000
Owner earnings: -4437000
Return on net tangible assets (%): -2.9481923467930016
Buffett classification: The Gruesome
Stock price: 3.19
Shares outstanding: 24006212
Book value: 150499000
P/B ratio: 0.5088393695639174
Market cap (USD): 76579816.28
Debt to equity: 0.012079814483817168
Current ratio: 20.511310344827585
Quick ratio: 19.44096551724138
COGS to revenue (%): 97.4947807933194
R&D to revenue (%): 14.936420573163788
SG&A to revenue (%): 86.41108369709623
Free cash flow (dilution-adjusted): -4377000
Buyback yield (%): 0
Retained earnings: -344839000
Inventory turnover: 0.6619845360824742
Receivables turnover: 1.45472114853672
Capitalized R&D asset: 787000
ROCI (R&D-adjusted, %): -3.0756365801548107
FCF margin (%): -83.0707914215221
Rule of 40 score: -83.0707914215221
Financial ratios for INVE — quarterly report dated 2025-06-30
Total revenue: 5040000
Gross profit: -474000
Operating income: -5967000
Net income: -6042000
Capital expenditures: 252000
Operating cash flow: -3568000
Depreciation & amortization: 634000
Net tangible assets: 146415000
Owner earnings: -5660000
Return on net tangible assets (%): -3.865724140286173
Buffett classification: The Gruesome
Stock price: 3.26
Shares outstanding: 24006212
Book value: 146415000
P/B ratio: 0.5345097914831131
Market cap (USD): 78260251.11999999
Debt to equity: 0.01150838370385548
Current ratio: 21.69707919301415
Quick ratio: 20.773712737127372
COGS to revenue (%): 109.40476190476191
R&D to revenue (%): 17.658730158730158
SG&A to revenue (%): 91.32936507936508
Free cash flow (dilution-adjusted): -4727000
Buyback yield (%): 0
Retained earnings: -350881000
Inventory turnover: 0.8990706016631339
Receivables turnover: 1.454125793421812
Capitalized R&D asset: 1417290
ROCI (R&D-adjusted, %): -3.7914235389413706
Rosenberg metric: -0.770012706480305
FCF margin (%): -93.78968253968254
Revenue growth (%): -4.346175744923135
Rule of 40 score: -98.13585828460567
Financial ratios for INVE — quarterly report dated 2025-09-30
Total revenue: 5009000
Gross profit: 534000
Operating income: -5180000
Net income: -3451000
Capital expenditures: 352000
Operating cash flow: -2881000
Depreciation & amortization: 616000
Net tangible assets: 143665000
Owner earnings: -3187000
Return on net tangible assets (%): -2.2183552013364425
Buffett classification: The Gruesome
Stock price: 3.45
Shares outstanding: 24006212
Book value: 143665000
P/B ratio: 0.5764899690251627
Market cap (USD): 82821431.4
Debt to equity: 0.010141648975046115
Current ratio: 21.078748331603144
Quick ratio: 20.20243215186119
COGS to revenue (%): 89.33918945897385
R&D to revenue (%): 16.530245557995606
SG&A to revenue (%): 97.54442004392094
Free cash flow (dilution-adjusted): -3941000
Buyback yield (%): 0
Retained earnings: -354332000
Inventory turnover: 0.7573193433745135
Receivables turnover: 1.1376334317510788
Capitalized R&D asset: 1684010
ROCI (R&D-adjusted, %): -3.5535913709730846
Rosenberg metric: 1.1325842696629214
FCF margin (%): -78.67837891794768
Revenue growth (%): -0.6150793650793651
Rule of 40 score: -79.29345828302705
Financial ratios for INVE — annual report dated 2025-12-31
Total revenue: 21484000
Gross profit: 1307000
Operating income: -20622000
Net income: -18003000
Capital expenditures: 1108000
Operating cash flow: -6703000
Depreciation & amortization: 2450000
Net tangible assets: 140701000
Owner earnings: -16661000
Return on net tangible assets (%): -11.841422591168506
Buffett classification: The Gruesome
Stock price: 3.84
Shares outstanding: 24006212
Book value: 140701000
P/B ratio: 0.6551755430309664
Market cap (USD): 92183854.08
Debt to equity: 0.00608382314269266
Current ratio: 15.188438198658575
Quick ratio: 14.398594698179496
COGS to revenue (%): 93.91640290448706
R&D to revenue (%): 15.257866319121208
SG&A to revenue (%): 86.81344256190654
Free cash flow (dilution-adjusted): -11013000
Buyback yield (%): 0
Retained earnings: -358053000
Inventory turnover: 2.719638765332255
Receivables turnover: 5.278624078624079
Capitalized R&D asset: 7333960
ROCI (R&D-adjusted, %): -14.200801422170203
Rosenberg metric: 0.24877797787496783
FCF margin (%): -51.2614038354124
Revenue growth (%): -19.31801111611837
Rule of 40 score: -70.57941495153077
Financial ratios for INVE — quarterly report dated 2025-12-31
Total revenue: 6166000
Gross profit: 1115000
Operating income: -4267000
Net income: -3721000
Capital expenditures: 203000
Operating cash flow: 3026000
Depreciation & amortization: 547000
Net tangible assets: 140701000
Owner earnings: -3377000
Return on net tangible assets (%): -2.4001250879524667
Buffett classification: The Gruesome
Stock price: 3.84
Shares outstanding: 24006212
Book value: 140701000
P/B ratio: 0.6551755430309664
Market cap (USD): 92183854.08
Debt to equity: 0.00608382314269266
Current ratio: 15.188438198658575
Quick ratio: 14.398594698179496
COGS to revenue (%): 81.91696399610768
R&D to revenue (%): 12.53649043139799
SG&A to revenue (%): 74.74862147259164
Free cash flow (dilution-adjusted): 2032000
Buyback yield (%): 0
Retained earnings: -358053000
Inventory turnover: 0.6808195174551827
Receivables turnover: 1.514987714987715
Capitalized R&D asset: 1621460
ROCI (R&D-adjusted, %): -3.0120986853894616
Rosenberg metric: 0.7016908212560387
FCF margin (%): 32.954914044761594
Revenue growth (%): 23.09842283889
Rule of 40 score: 56.053336883651596
Financial ratios for IPW — annual report dated 2021-06-30
Total revenue: 54075922
Gross profit: 22818564
Operating income: 2960564
Net income: -775749
Capital expenditures: 61498
Operating cash flow: -12756949
Depreciation & amortization: 12091
Net tangible assets: 24985785
Owner earnings: -825156
Return on net tangible assets (%): -3.302501802524916
Capex to operating income (%): 2.077239336829064
Buffett classification: The Great
Stock price: 1704
Shares outstanding: 1891147
Book value: 24985785
P/B ratio: 128.97391408755018
Market cap (USD): 3222514488
Debt to equity: 0.10214127753040379
Current ratio: 3.579738926804967
Quick ratio: 2.131995671531946
COGS to revenue (%): 57.80272780184866
SG&A to revenue (%): 36.72244367835282
Free cash flow (dilution-adjusted): -12929130
Buyback yield (%): 0
Retained earnings: 1745073
Inventory turnover: 2.3923142208314094
Receivables turnover: 6.273511141078564
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.124123522182462
FCF margin (%): -23.9092178585508
Rule of 40 score: -23.9092178585508
Financial ratios for IPW — annual report dated 2022-06-30
Total revenue: 79418473
Gross profit: 33199893
Operating income: 2312037
Net income: 1517875
Capital expenditures: 484172
Operating cash flow: -16603005
Depreciation & amortization: 277924
Net tangible assets: 21386476
Owner earnings: 1311627
Return on net tangible assets (%): 6.132973941101844
Capex to operating income (%): 20.94136036750277
Buffett classification: The Great
Stock price: 261.6
P/E ratio: 325.93201363748665
Shares outstanding: 1891147
Book value: 32396830
P/B ratio: 15.27075504609556
Market cap (USD): 494724055.20000005
Debt to equity: 0.8279804227759321
Current ratio: 2.4115207240965235
Quick ratio: 1.0815816441999742
Effective tax rate (%): 27.08713531283406
Interest coverage ratio: 5.046363816928184
COGS to revenue (%): 58.1962586966385
SG&A to revenue (%): 38.89253322712462
Free cash flow (dilution-adjusted): -17459528
Buyback yield (%): 0
Retained earnings: 3262948
Inventory turnover: 1.5186612133378432
Receivables turnover: 4.26647426872235
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.151031723141818
FCF margin (%): -21.984215183789797
Revenue growth (%): 46.86475988333588
Rule of 40 score: 24.880544699546082
Financial ratios for IPW — annual report dated 2023-06-30
Total revenue: 88902048
Gross profit: 34797461
Operating income: -10423509
Net income: -11965390
Capital expenditures: 140813
Operating cash flow: 9211269
Depreciation & amortization: 3412312
Net tangible assets: 13575475
Owner earnings: -8693891
Return on net tangible assets (%): -64.04115509770376
Buffett classification: The Gruesome
Stock price: 264
Shares outstanding: 1891147
Book value: 20864741
P/B ratio: 23.928540881480387
Market cap (USD): 499262808
Debt to equity: 0.9621141714627562
Current ratio: 1.76833213413778
Quick ratio: 0.8856981058196215
Interest coverage ratio: -9.775583336459466
COGS to revenue (%): 60.858650860326634
SG&A to revenue (%): 50.866061038323885
Free cash flow (dilution-adjusted): 8557660
Buyback yield (%): 0
Retained earnings: -8702442
Inventory turnover: 2.6272156269269975
Receivables turnover: 5.842727135549724
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -28.354047533730437
FCF margin (%): 9.62594247547593
Revenue growth (%): 11.941270892982292
Rule of 40 score: 21.567213368458223
Financial ratios for IPW — annual report dated 2024-06-30
Total revenue: 86071485
Gross profit: 38121368
Operating income: -962892
Net income: -1528159
Capital expenditures: 0
Operating cash flow: 6164077
Depreciation & amortization: 2509407
Net tangible assets: 16389427
Owner earnings: 981248
Buffett classification: The Gruesome
Stock price: 499.2
Shares outstanding: 1891147
Book value: 23016033
P/B ratio: 41.01751950042824
Market cap (USD): 944060582.4
Debt to equity: 0.5600905681704575
Current ratio: 1.472895031828966
Quick ratio: 1.029215337053847
Interest coverage ratio: -1.2212854742049022
COGS to revenue (%): 55.70964297874029
SG&A to revenue (%): 45.409068984925725
Free cash flow (dilution-adjusted): 5651535
Buyback yield (%): 0
Retained earnings: -10230601
Inventory turnover: 4.546640979235034
Receivables turnover: 5.557443911753161
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.4981382222567436
FCF margin (%): 6.566094450444303
Revenue growth (%): -3.1839120286632765
Rule of 40 score: 3.3821824217810263
Financial ratios for IPW — quarterly report dated 2024-09-30
Capital expenditures: 202140
Buffett classification: The Gruesome
Stock price: 434.4
Shares outstanding: 1891147
Market cap (USD): 821514256.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPW — quarterly report dated 2024-12-31
Total revenue: 19072571
Gross profit: 8389886
Operating income: 683607
Net income: 218819
Capital expenditures: 462226
Operating cash flow: 27717
Depreciation & amortization: 606173
Net tangible assets: 15408000
Owner earnings: 362766
Return on net tangible assets (%): 2.3544003115264798
Capex to operating income (%): 67.615749985006
Buffett classification: The Good
Stock price: 199.92
P/E ratio: 431.95301623716404
Shares outstanding: 1891147
Book value: 21703929
P/B ratio: 17.419800269342936
Market cap (USD): 378078108.23999995
Debt to equity: 0.43981806243468635
Current ratio: 1.9489534706864078
Quick ratio: 1.3160573452841382
Effective tax rate (%): 35.84769837138395
Interest coverage ratio: 4.859581153321201
COGS to revenue (%): 56.010723462505396
SG&A to revenue (%): 40.40503506318052
Free cash flow (dilution-adjusted): -631822
Buyback yield (%): 0
Retained earnings: -12041063
Inventory turnover: 1.1632310792975022
Receivables turnover: 1.327238947562757
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3284342819267017
FCF margin (%): -3.312725903602613
Rule of 40 score: -3.312725903602613
Financial ratios for IPW — quarterly report dated 2025-03-31
Total revenue: 16041672
Gross profit: 6855460
Operating income: -334504
Net income: -339599
Capital expenditures: 855562
Operating cash flow: 887712
Depreciation & amortization: 669720
Net tangible assets: 14587135
Owner earnings: -525441
Return on net tangible assets (%): -3.602084987902011
Buffett classification: The Gruesome
Stock price: 120
Shares outstanding: 1891147
Book value: 20717947
P/B ratio: 10.953674126109116
Market cap (USD): 226937640
Debt to equity: 0.39741066042885426
Current ratio: 1.915878301219566
Quick ratio: 1.1610634373735
Interest coverage ratio: -4.080909623267616
COGS to revenue (%): 57.264679143171605
SG&A to revenue (%): 44.8205399038205
Free cash flow (dilution-adjusted): 578203
Buyback yield (%): 0
Retained earnings: -12380662
Inventory turnover: 0.939987203125769
Receivables turnover: 1.5023944022348503
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.213759374591563
FCF margin (%): 3.6043811393226344
Revenue growth (%): -15.891402370451264
Rule of 40 score: -12.28702123112863
Financial ratios for IPW — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 155.28
Shares outstanding: 1891147
Market cap (USD): 293657306.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPW — annual report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 155.28
Shares outstanding: 1891147
Market cap (USD): 293657306.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPW — quarterly report dated 2025-09-30
Total revenue: 12017467
Gross profit: 4806524
Operating income: -1695179
Net income: -533648
Capital expenditures: 583633
Operating cash flow: 1686463
Depreciation & amortization: 510577
Net tangible assets: 12111866
Owner earnings: -606704
Return on net tangible assets (%): -5.009170345841012
Buffett classification: The Gruesome
Stock price: 124.32
Shares outstanding: 1891147
Book value: 17917500
P/B ratio: 13.121662901632481
Market cap (USD): 235107395.04
Debt to equity: 0.3290289381889214
Current ratio: 1.4576612729393534
Quick ratio: 0.9240031335104555
Interest coverage ratio: -27.46608013739691
COGS to revenue (%): 60.00385106112628
SG&A to revenue (%): 54.10210820633
Free cash flow (dilution-adjusted): 952627
Buyback yield (%): 0
Retained earnings: -15732537
Inventory turnover: 1.6643435069663632
Receivables turnover: 2.2213576243099538
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.279827039733698
FCF margin (%): 7.927019895290746
Rule of 40 score: 7.927019895290746
Financial ratios for IPW — quarterly report dated 2025-12-31
Total revenue: 7133602
Gross profit: 3138922
Operating income: -2437977
Net income: -1193281
Capital expenditures: 2347356
Operating cash flow: -922557
Depreciation & amortization: 513961
Net tangible assets: 12341051
Owner earnings: -3026676
Return on net tangible assets (%): -24.525269363200913
Buffett classification: The Gruesome
Stock price: 59.84
Shares outstanding: 1891147
Book value: 17984342
P/B ratio: 6.2924869022174965
Market cap (USD): 113166236.48
Debt to equity: 0.5870421614535578
Current ratio: 1.830927565771978
Quick ratio: 1.3808217269535443
Interest coverage ratio: -14.5792838262908
COGS to revenue (%): 55.99807782940511
SG&A to revenue (%): 78.1778826461022
Free cash flow (dilution-adjusted): -4241087
Buyback yield (%): 0
Retained earnings: -16925818
Inventory turnover: 1.105990017882758
Receivables turnover: 1.2036632956364688
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.386646549227496
FCF margin (%): -59.45225147127636
Revenue growth (%): -40.63972050016863
Rule of 40 score: -100.09197197144499
Financial ratios for IWS.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.654503990877993
Shares outstanding: 39955058
Market cap (USD): 146015918.9167617
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IWS.OL — annual report dated 2022-12-31
Total revenue: 2160323.886639676
Gross profit: 738663.9676113359
Operating income: -284109.31174089067
Net income: -248785.42510121455
Capital expenditures: 4430161.943319838
Operating cash flow: -623684.2105263157
Depreciation & amortization: 60121.457489878536
Net tangible assets: 8965080.97165992
Owner earnings: -4618825.910931174
Return on net tangible assets (%): -51.5201806378775
Buffett classification: The Gruesome
Stock price: 3.266194331983806
Shares outstanding: 39955058
Book value: 9900809.716599189
P/B ratio: 13.180839518094462
Market cap (USD): 130500983.97368422
Debt to equity: 0.01702105908812104
Current ratio: 5.002893518518518
Quick ratio: 0.5857928240740741
Interest coverage ratio: -12.15151515151515
COGS to revenue (%): 65.80772113943027
SG&A to revenue (%): 3.7106446776611692
Free cash flow (dilution-adjusted): -5053846.153846153
Buyback yield (%): 0
Retained earnings: -446153.8461538461
Inventory turnover: 0.4600569912547902
Receivables turnover: 2.8443496801705757
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.848878514158125
FCF margin (%): -233.93928035982006
Rule of 40 score: -233.93928035982006
Financial ratios for IWS.OL — annual report dated 2023-12-31
Total revenue: 2220039.292730845
Gross profit: 1045972.4950884087
Operating income: -351178.78192534385
Net income: -115913.55599214145
Capital expenditures: 4813948.919449902
Operating cash flow: -68172.8880157171
Depreciation & amortization: 54715.12770137525
Net tangible assets: 11179076.620825147
Owner earnings: -4875147.347740669
Return on net tangible assets (%): -43.6095709251953
Buffett classification: The Gruesome
Stock price: 3.9803536345776034
Shares outstanding: 39955058
Book value: 12089292.730844794
P/B ratio: 13.155050826446953
Market cap (USD): 159035260.33005896
Debt to equity: 0.24293688906223337
Current ratio: 4.131897055956327
Quick ratio: 4.131897055956327
Interest coverage ratio: -29.54545454545455
COGS to revenue (%): 52.884955752212385
SG&A to revenue (%): 0.9690265486725663
Free cash flow (dilution-adjusted): -4887328.094302555
Buyback yield (%): 0
Retained earnings: -1429371.3163064832
Receivables turnover: 4.4080358884337825
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.385050569743549
FCF margin (%): -220.14601769911505
Revenue growth (%): 2.764187650771878
Rule of 40 score: -217.38183004834318
Financial ratios for IWS.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.609732824427481
Shares outstanding: 39955058
Market cap (USD): 184182142.36450383
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0